Literature DB >> 8580718

Huntington's disease: CAG genetics expands neurobiology.

J F Gusella1, M E MacDonald.   

Abstract

Huntington's disease, with its progressive uncontrolled movements and characteristic selective neuropathology, has represented a baffling enigma to geneticists and neurobiologists alike. Discovery of the HD gene and its defect has demystified the genetic aspects of the disorder, but has not yet explained its pathogenesis. Attempts to explore this issue suggest that the defect acts as a gain of function, conferring a new deleterious property on the huntingtin protein, and that the gene's normal function may be irrelevant to the disease process.

Entities:  

Mesh:

Year:  1995        PMID: 8580718     DOI: 10.1016/0959-4388(95)80072-7

Source DB:  PubMed          Journal:  Curr Opin Neurobiol        ISSN: 0959-4388            Impact factor:   6.627


  14 in total

1.  Evaluation of CAG repeat length of androgen receptor expressing cells in human testes showing different pictures of spermatogenic impairment.

Authors:  Daniela Fietz; Joachim Geyer; Sabine Kliesch; Jörg Gromoll; Martin Bergmann
Journal:  Histochem Cell Biol       Date:  2011-10-25       Impact factor: 4.304

2.  Rhes, a physiologic regulator of sumoylation, enhances cross-sumoylation between the basic sumoylation enzymes E1 and Ubc9.

Authors:  Srinivasa Subramaniam; Robert G Mealer; Katherine M Sixt; Roxanne K Barrow; Alessandro Usiello; Solomon H Snyder
Journal:  J Biol Chem       Date:  2010-04-27       Impact factor: 5.157

Review 3.  The genetic epidemiology of neurodegenerative disease.

Authors:  Lars Bertram; Rudolph E Tanzi
Journal:  J Clin Invest       Date:  2005-06       Impact factor: 14.808

4.  Inhibition of calcineurin by FK506 protects against polyglutamine-huntingtin toxicity through an increase of huntingtin phosphorylation at S421.

Authors:  Raúl Pardo; Emilie Colin; Etienne Régulier; Patrick Aebischer; Nicole Déglon; Sandrine Humbert; Frédéric Saudou
Journal:  J Neurosci       Date:  2006-02-01       Impact factor: 6.167

5.  Polyglutamine aggregates alter protein folding homeostasis in Caenorhabditis elegans.

Authors:  S H Satyal; E Schmidt; K Kitagawa; N Sondheimer; S Lindquist; J M Kramer; R I Morimoto
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

Review 6.  Autophagy of mitochondria: a promising therapeutic target for neurodegenerative disease.

Authors:  Pradip K Kamat; Anuradha Kalani; Philip Kyles; Suresh C Tyagi; Neetu Tyagi
Journal:  Cell Biochem Biophys       Date:  2014-11       Impact factor: 2.194

7.  Polyglutamine-mediated dysfunction and apoptotic death of a Caenorhabditis elegans sensory neuron.

Authors:  P W Faber; J R Alter; M E MacDonald; A C Hart
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-05       Impact factor: 11.205

8.  Does the Mutant CAG Expansion in Huntingtin mRNA Interfere with Exonucleolytic Cleavage of its First Exon?

Authors:  Wanzhao Liu; Edith L Pfister; Lori A Kennington; Kathryn O Chase; Christian Mueller; Marian DiFiglia; Neil Aronin
Journal:  J Huntingtons Dis       Date:  2016

9.  Identification of potential therapeutic drugs for huntington's disease using Caenorhabditis elegans.

Authors:  Cindy Voisine; Hemant Varma; Nicola Walker; Emily A Bates; Brent R Stockwell; Anne C Hart
Journal:  PLoS One       Date:  2007-06-06       Impact factor: 3.240

10.  Detection of Huntington's disease decades before diagnosis: the Predict-HD study.

Authors:  J S Paulsen; D R Langbehn; J C Stout; E Aylward; C A Ross; M Nance; M Guttman; S Johnson; M MacDonald; L J Beglinger; K Duff; E Kayson; K Biglan; I Shoulson; D Oakes; M Hayden
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-12-20       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.